“A Growth Trajectory”: How Accumold Benefits from the 2025 Tax Law

Precision micro molding company Accumold has just one location—in Ankeny, Iowa, a suburb of Des Moines—but it ships to more than 30 countries per year. So what makes this booming business possible? One major factor: competitive tax policy.

What’s going on: H.R. 1, the landmark tax law passed almost one year ago, “supports our growth, and it is that growth that allows us to invest with our capital expenditures” and research and development, Accumold Technical Marketing Manager Brett Saddoris told the NAM in a recent interview.

• “It’s significantly reduced our taxes. … It’s supporting the guys [who] are coming up with the ideas [on our team]. It’s giving them the best tools to use to succeed at their jobs.”

Research and development: The advanced manufacturer has been able “to continue investing to meet the demand of our customers” thanks to the bill’s restoration of immediate R&D expensing, Saddoris said.

• “We constantly have to be ready to support our high-tech medical customers with the [requests] they bring to us,” he continued, adding that immediate expensing saves money that can be poured back into R&D, helping the company “learn before the customer even shows up.”

Full expensing: The tax bill’s full expensing provision—which allows manufacturers to immediately expense the full cost of capital equipment purchases—meant “we could invest in machines that alleviated bottlenecks in our process,” Saddoris told the NAM.

• “So we could continue to make more molds, more machines. So we didn’t have to say ‘no’ to some customers that are going to be very large down the road [but] right now are a little bit smaller. … Our growth [would have been] completely stunted if we were not able to” do that.

The last word: “We’re seeing 360-plus [employees] right now,” Saddoris said. “We are in a growth trajectory. There’s a great chance a year from now we could be [at] 450, 100 more, potentially.”